$AMRZ

Amrize Ltd (AMRZ) Q3 2026 Earnings Call Highlights: Pricing Power Drives Growth

Amrize Ltd (AMRZ) reported Q3 2026 earnings, with revenue and EBITDA guidance updated to $12.2-$12.4B and $2.95-$3.05B. Cement volumes fell 4.2% YoY due to weather, while building envelope EBITDA declined 14.6% from inflation. Price-cost positivity in building envelope delayed to 2027. CEO Jan Jenisch expects 2027 growth but cites inflation and interest rate uncertainties. Free cash flow conversion below 50% target due to higher CapEx.

Original reporting
Published Oct 29, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amrize Ltd (AMRZ) Q3 2026 Earnings Call Highlights: Pricing Power Drives Growth — source image
Decision brief

The 30-second read

$AMRZBearishMed
01

Why it matters

Traders should focus on the updated revenue and EBITDA ranges, the expectation that building-envelope price-cost positivity is delayed to 2027, and the implications for Q4 volumes and free cash flow conversion.

02

Market read

Updated guidance and delayed margin timing are likely to drive near-term estimate revisions and positioning for Q4 and 2027 profitability.

03

What to watch

Cash flow conversion is expected to be below the 50% mid-term target this year due to higher CapEx, but benefits are expected in subsequent quarters and particularly next year, which could offset near-term earnings caution.

Relevance 7/10Novelty 6/10Timing: after-hours earnings call, guidance update for the current fiscal year

Background

The piece summarizes Amrize’s Q3 2026 earnings call, focusing on pricing power, volume softness, margin pressures from inflation, and updated full-year guidance.

Company-level read

Ticker impact

$AMRZBearishHigh confidence
Context

Amrize updated full-year revenue to $12.2-$12.4B and EBITDA to $2.95-$3.05B, citing softer Q4 volumes and delayed building-envelope price-cost positivity to 2027.

Expected impact

Likely downside pressure as investors reprice Q4 caution and the delayed 2027 price-cost inflection, despite confidence in building materials pricing.

Evidence & confidence

The article contains explicit updated full-year guidance ranges and a clear delay in building-envelope price-cost positivity to 2027, both directly affecting earnings expectations.

Market effects

Signals continued pricing power in building materials but weaker residential roofing demand and inflation-driven margin pressure, which can influence sentiment across construction materials peers.

Weather-driven volume weakness in key regions (including Texan weather effects) highlights regional demand volatility for aggregates and cement.

Management attributes margin pressure to global inflation in freight, diesel, and raw materials, reinforcing macro sensitivity for construction inputs.

Counterpoint

Despite the delayed building-envelope inflection, management expects building materials to remain price-over-cost positive in Q4 and cites margin expansion momentum (cement and aggregates pricing plus surcharges).

Key entities

  • Amrize Ltd

    Construction materials producer discussing Q3 pricing/volume trends and updating full-year guidance and margin timing.

  • Jan Jenisch

    CEO quoted on pricing power, cost recovery uncertainty, and delayed building-envelope profitability timing.

  • Samuel Poletti

    CFO quoted on free cash flow conversion expectations and seasonal cash dynamics.

Related articles

Med

Amrize Q3 2026 slides: pricing drives margins amid volume headwinds

Amrize reported Q3 2026 revenues of $3.77B, up 2.2% YoY, with net income rising 3.3% to $558M. Pricing initiatives and acquisitions offset volume declines due to weather. Building Materials segment grew 1.8%, while Building Envelope faced challenges. Guidance updated to $12.2B-$12.4B in revenue and $2.95B-$3.05B in adjusted EBITDA for 2026.

$AMRZMed

DA Davidson raises Amrize stock price target to $43 on mixed Q3

DA Davidson raised its price target for Amrize (NYSE:AMRZ) to $43, citing mixed Q3 results with strong Building Materials offset by Building Envelope pressure. The stock is up 5.5% weekly but down 22% in six months. Amrize guided below consensus but beat EPS estimates by 2.06% while missing revenue by 0.95%. DA Davidson maintains a Neutral rating, awaiting more execution visibility.

$AMRZHighAI 9/10

What Amrize (AMRZ) Said on Its Q3 Earnings Call

Amrize (AMRZ) reported Q3 revenue growth of 1.8% to $2.8B in Building Materials and 3.6% to $929M in Building Envelope. Adjusted EBITDA rose 2.7% in Building Materials but fell 14.6% in Building Envelope due to higher costs. The company expects price-over-cost positivity in Building Envelope by 2027. Amrize reaffirmed its 2026 outlook, targeting $12.2B-$12.4B in revenue and $2.95B-$3.05B in EBITDA. It returned $1.1B to shareholders through dividends and repurchases.

$AMRZMed

Amrize (AMRZ) Q3 2026 Earnings Call Transcript

Amrize (AMRZ) reported Q3 2026 earnings, highlighting strong pricing growth and operational efficiency. The company saw solid commercial roofing momentum but softer residential roofing due to lower home sales. Amrize completed $262M in CapEx and acquired PB Materials and Rapid Redi-Mix, strengthening its Texas market presence. The company returned $1.1B to shareholders via dividends and share repurchases, completing a $1B buyback program.

Med

Why is Amrize stock sliding today?

Amrize AG's stock is down 5.3% in pre-market trading after Q3 2026 results missed revenue expectations and the company lowered its full-year adjusted EBITDA guidance to $2.95–$3.05 billion. Revenue was $3.77 billion, up 2.2% YoY but below consensus. Management cited inflation-driven cost increases. The stock is near its 52-week low.